Hepatitis B Package
Understanding Hepatitis B Package
What is Hepatitis B Package?
The Hepatitis B Package is a comprehensive package that assesses various markers related to hepatitis B virus (HBV) infection. This package includes essential blood tests that help diagnose current hepatitis B infections, monitor immune responses, and evaluate potential recovery from the virus.
Hepatitis B is an infectious disease characterized by inflammation of the liver, primarily caused by the hepatitis B virus (HBV). The virus is transmitted through contact with infected body fluids, such as blood, semen, or vaginal secretions, often through unprotected sex, sharing needles, or from mother to child at birth. Some individuals may have no symptoms, while others may experience symptoms like fatigue, jaundice, abdominal pain, nausea, and dark urine.
The Hepatitis B Package includes critical markers that assist in identifying both active and resolved hepatitis B infection. Each test in this package serves a unique purpose 一 Hepatitis B Surface Antigen (HBsAg) test detects the presence of the virus in the blood, indicating an active infection that can be transmitted to others. Hepatitis B (Core) IgM Antibody test helps determine recent infections, indicating that the individual has been exposed to the virus within the last few months. Hepatitis B e (Envelope) Antigen test indicates viral replication and can signify a higher level of infectivity. Hepatitis B e (Envelope) Antibody test suggests recovery from infection and a lower risk of transmission. Hepatitis B s (Surface) Antibody test signifies recovery and immunity from Hepatitis B, whether through infection or vaccination. Lastly, Hepatitis B (Core) Total Antibody test detects both IgM and IgG antibodies, providing information on both recent and past infections.
This package is essential for individuals experiencing symptoms of hepatitis, those at risk of infection, and those requiring monitoring for chronic HBV infection. Accurate testing enables doctors to differentiate between active, chronic, and resolved infections, guiding treatment decisions effectively. Early detection also plays a critical role in preventing further transmission and managing any complications that may arise from the infection.
No special preparation is needed for this test. The individual may eat and drink as per the daily routine. However, they must inform the doctor about any medications that they take or if they have a history of any bleeding disorders or recent vaccinations, as these factors may influence the test results.
Lab test results may vary across laboratories. Talk to the doctor about the specific test results. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate based solely on these results. Always consult a doctor for a proper understanding of the test results.
What is Hepatitis B Package used for?
The Hepatitis B Package is done:
- To confirm the presence of hepatitis B virus in individuals showing symptoms of hepatitis B such as stomach pain, joint pain, dark-colored urine, light-colored stool, and the yellowing of skin and eyes (jaundice) or at risk of infection.
- To determine whether the infection is acute or chronic based on specific antibodies and antigen markers.
- To determine if an individual is currently infected with hepatitis B or has been exposed in the past.
- To evaluate active viral replication, which can influence treatment decisions and transmission risk.
- To assess whether an individual has recovered from hepatitis B or achieved immunity through vaccination.
- To identify individuals who may require further monitoring or treatment to prevent liver damage or complications.
- To assess the need for antiviral therapy and evaluate liver function.
- To proactively test individuals at higher risk, such as pregnant women and those with liver disease.
What does Hepatitis B Package measure?
Contains 6 testsThe Hepatitis B Package measures key markers related to the hepatitis B virus (HBV) to assess infection status and immune response. It includes the Hepatitis B Surface Antigen (HBsAg), which indicates an active infection, and the Hepatitis B Core IgM Antibody, suggesting a recent infection. The package also tests for Hepatitis B e Antibody (anti-HBe), indicating recovery from infection and a lower risk of transmission and Hepatitis B e Antigen (HBeAg), signifying active replication and higher infectivity. Additionally, Hepatitis B Surface Antibody (anti-HBs) reflects recovery or immunity from vaccination, while Hepatitis B Core Total Antibody (anti-HBc) indicates past or present infection. By analyzing these biomarkers collectively, doctors can tailor treatment strategies, monitor disease progression, and optimize patient outcomes, improving liver health and preventing long-term complications associated with hepatitis B.
Hepatitis B Surface Antigen (HBsAg)
The Hepatitis B Surface Antigen (HBsAg) test detects the presence of a specific protein on the surface of the Hepatitis B virus (HBV) in the bloodstream. This protein, HBsAg, serves as a crucial marker for identifying HBV infection. This is a screening test and the diagnosis of any reactive HBsAg result relies on additional supplemental tests like anti-HBs antibody and total anti-HBc antibodies. Confirmation can be done using nucleic acid tests like HBV DNA by PCR. The Hepatitis B Surface Antigen (HBsAg) test is essential for identifying individuals who require medical intervention, such as antiviral therapy, and for implementing measures to prevent the spread of Hepatitis B virus to others.
Know more about Hepatitis B Surface Antigen (HBsAg)
Hepatitis B (Core) IgM Antibody
Hepatitis B e (Envelope) Antibody
HBeAg (Hepatitis B Envelope Antigen)
The HBeAg (Hepatitis B Envelope Antigen) test measures the presence of the HBeAg in the blood, indicating active viral replication. A positive result signifies that the virus is replicating at a high level, suggesting a higher risk of transmission to others and potential progression to more severe liver disease. Conversely, a negative result may indicate lower viral activity or that the virus is in a non-replicative state.
Understanding the significance of HBeAg status is crucial in managing chronic hepatitis B infection. It helps guide treatment decisions, informs about the potential for liver damage, and aids in assessing the effectiveness of therapeutic interventions. Regular monitoring through this test can play a pivotal role in maintaining liver health and preventing complications associated with chronic hepatitis B.
Know more about HBeAg (Hepatitis B Envelope Antigen)
Anti-HBs (Hepatitis B Surface antibody)
The Anti-HBs (Hepatitis B Surface antibody) test measures the presence of antibodies produced by the immune system against hepatitis B virus (HBV) or the hepatitis B vaccine (immunity) in vaccinated individuals. There are two types of antibodies produced in response to the hepatitis B virus: Immunoglobulin M (IgM) and Immunoglobulin G (IgG). IgM antibodies mount the first attack against HBV but eventually fades away. IgG antibodies provide long-lasting immune protection against HBV. The immunity can last for many years, but it gradually decreases over time.
A positive test result indicates immunity to hepatitis B, either from past infection and subsequent recovery or from vaccination. The Anti-HBs (Hepatitis B Surface antibody) test is important to determine whether you have protective immunity against HBV and if you are at risk of contracting the virus in the future. It can also help guide decisions on whether you need the hepatitis B vaccine or a booster shot to maintain immunity.
Know more about Anti-HBs (Hepatitis B Surface antibody)
Hepatitis B (Core) Total Antibody
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Hepatitis B Package
Frequently Asked Questions about Hepatitis B Package
Q. What is the Hepatitis B Package?
Q. What is included in the Hepatitis B Package?
Q. Why should I get tested for hepatitis B?
Q. How is the Hepatitis B Package performed?
Q. How often should I be tested for hepatitis B?
Q. Can I spread hepatitis B if I have a positive test?
Q. Is there any treatment for hepatitis B?
Q. Can hepatitis B be prevented?
Q. What should I do if my test results are abnormal?
Q. What happens if you are a hepatitis B carrier?
Q. How does Tata 1mg ensure accurate lab test results?
Book a Hepatitis B Package test at home near me
References
- Hepatitis B [Internet]. World Health Organization; 09 Apr. 2024 [Accessed 24 Oct. 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
- Hepatitis B [Internet]. CDC; 12 Jan. 2024 [Accessed 24 Oct. 2024]. Available from: https://www.cdc.gov/hepatitis-b/#:~:text=Hepatitis%20B%20is%20a%20vaccine,someone%20who%20is%20not%20infected
- Song JE, Kim DY. Diagnosis of hepatitis B. Ann Transl Med. 2016 Sep;4(18):338. [Accessed 24 Oct. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066055/#r8
- Hepatitis B [Internet]. Healthdirect; March 2024 [Accessed 24 Oct. 2024]. Available from: https://www.healthdirect.gov.au/hepatitis-b
- Yao QQ, Dong XL, Wang XC, Ge SX, Hu AQ, Liu HY, Wang YA, Yuan Q, Zheng YJ. Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination. Clin Vaccine Immunol. 2013 Feb;20(2):269-75. [Accessed 24 Oct. 2024]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3571284/
- Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J. 2011 Nov 10;8:513. [Accessed 24 Oct. 2024]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3239416/
- Roggendorf M, Deinhardt F, Frösner GG, Scheid R, Bayerl B, Zachoval R. Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection. J Clin Microbiol. 1981 Apr;13(4):618-26. [Accessed 24 Oct. 2024]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC273847/
- Norouzirad R, Shakurnia AH, Assarehzadegan MA, Serajian A, Khabazkhoob M. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran. Hepat Mon. 2014 Jan 12;14(1):e13625. [Accessed 24 Oct. 2024]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3909642/
- Shi Y, Wang Z, Ge S, Xia N, Yuan Q. Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections. Viruses. 2023 May 3;15(5):1111. [Accessed 24 Oct. 2024]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10221631/
Other tests
